# Radnostix Inc (INIS)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/radnostix-inc/ JSON: https://steadybase.io/company/radnostix-inc.json Checked Nov 10, 2026. Latest filing read: Aug 26, 2026.

## Company

- Legal name: RADNOSTIX INC
- Ticker: INIS (OTC)
- SEC CIK: 0001038277
- Industry: Industrial Instruments For Measurement, Display, and Control (SIC 3823)
- Headquarters: Idaho Falls, ID
- Fiscal year ends: December 31
- SEC filer category: Non-accelerated filer<br>Smaller reporting company
- Website: radnostix.com
- Investor relations: https://radnostix.com/investor-center/
- LinkedIn: https://www.linkedin.com/company/international-isotopes-inc
- Next earnings date: Nov 13, 2026 (estimated from past 8-K timing)

## Key facts

- Revenue: $13.1M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 31, 2026). Source: https://www.sec.gov/Archives/edgar/data/1038277/000143774926010700/0001437749-26-010700-index.html
- Operating income: -$956,187 for the fiscal year ended Dec 31, 2025 (10-K filed Mar 31, 2026). Source: https://www.sec.gov/Archives/edgar/data/1038277/000143774926010700/0001437749-26-010700-index.html
- Net income: -$908,002 for the fiscal year ended Dec 31, 2025 (10-K filed Mar 31, 2026). Source: https://www.sec.gov/Archives/edgar/data/1038277/000143774926010700/0001437749-26-010700-index.html
- SG&A: $3.7M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 31, 2026). Source: https://www.sec.gov/Archives/edgar/data/1038277/000143774926010700/0001437749-26-010700-index.html
- Employees: 45 as of Dec 31, 2025, as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/1038277/000143774926010700/inis20251231_10k.htm
- Shares outstanding: 529,154,204 as of Aug 10, 2026 (10-Q filed Aug 12, 2026). Source: https://www.sec.gov/Archives/edgar/data/1038277/000143774926027385/0001437749-26-027385-index.html
- Auditor: Haynie, Salt Lake City, UT, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/1038277/000143774926010700/inis20251231_10k.htm

## Business

Radnostix Inc. (the “Company”, “we”, “us” and “our”) manufactures a wide range of radioisotope-focused products used in variety of medical and industrial applications. We were formed as a Texas corporation in 1995. On December 23, 2025, we filed a Certificate of Amendment in the state of Texas for the sole purpose of amending our Certificate of Formation to change our corporate name from International Isotopes Inc. to Radnostix, Inc.

Source: Item 1. Business, https://www.sec.gov/Archives/edgar/data/1038277/000143774926010700/inis20251231_10k.htm

## Annual results

| Fiscal year ended | Revenue | Operating income | Net income | SG&A |
|---|---|---|---|---|
| Dec 31, 2025 | $13.1M | -$956,187 | -$908,002 | $3.7M |
| Dec 31, 2024 | $13.9M | $6,901 | $8,574 | $4.0M |
| Dec 31, 2023 | $12.3M | -$776,299 | -$869,016 | $3.5M |
| Dec 31, 2022 | $11.2M | -$1.2M | $303,238 | $3.6M |
| Dec 31, 2021 | $9.7M | -$680,792 | -$902,347 | $3.5M |

Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/radnostix-inc.json

## Officers and directors

- Shahe Bagerdjian, President, Chief Executive Officer, and Director. Source: 10-K filed Mar 31, 2026, https://www.sec.gov/Archives/edgar/data/1038277/000143774926010700/inis20251231_10k.htm
- W. Matthew Cox, Chief Financial Officer, Secretary. LinkedIn: https://linkedin.com/in/matthew-cox-95392533. Source: 10-K filed Mar 31, 2026, https://www.sec.gov/Archives/edgar/data/1038277/000143774926010700/inis20251231_10k.htm
- Christopher Grosso, Chairman of the Board of Directors. Source: 10-K filed Mar 31, 2026, https://www.sec.gov/Archives/edgar/data/1038277/000143774926010700/inis20251231_10k.htm
- Duke Fu, Director. Source: 10-K filed Mar 31, 2026, https://www.sec.gov/Archives/edgar/data/1038277/000143774926010700/inis20251231_10k.htm
- Robert Atcher, Director. Source: 10-K filed Mar 31, 2026, https://www.sec.gov/Archives/edgar/data/1038277/000143774926010700/inis20251231_10k.htm
- Steve Laflin, Director. Source: 10-K filed Mar 31, 2026, https://www.sec.gov/Archives/edgar/data/1038277/000143774926010700/inis20251231_10k.htm

## Recent 8-K events

- Oct 1, 2026: Item 1.01, Entry into a material definitive agreement; Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1038277/000143774926031655/inis20260930_8k.htm
- Jul 21, 2026: Item 5.02, Departure or appointment of directors or officers; compensation; Item 5.07, Submission of matters to a vote of security holders; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1038277/000143774926023964/inis20260720_8k.htm
- Jul 1, 2026: Item 1.01, Entry into a material definitive agreement; Item 2.01, Completion of acquisition or disposition of assets; Item 2.03, Creation of a direct financial obligation; Item 3.02, Unregistered sales of equity securities; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1038277/000143774926022282/inis20260629_8k.htm
- May 20, 2026: Item 3.03, Material modification to rights of security holders; Item 5.03, Amendments to articles or bylaws; change in fiscal year; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1038277/000143774926017929/inis20260519_8k.htm
- Mar 16, 2026: Item 1.02, Termination of a material definitive agreement; Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1038277/000143774926008319/inis20260313_8k.htm
- Dec 31, 2025: Item 5.03, Amendments to articles or bylaws; change in fiscal year; Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1038277/000143774925039001/inis20251230_8k.htm
- Oct 17, 2025: Item 5.02, Departure or appointment of directors or officers; compensation; Item 5.03, Amendments to articles or bylaws; change in fiscal year; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1038277/000143774925031242/inis20251016_8k.htm
- Oct 17, 2025: Item 5.02, Departure or appointment of directors or officers; compensation; Item 5.03, Amendments to articles or bylaws; change in fiscal year; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1038277/000143774925031241/inis20251016_8k.htm
- Jul 16, 2025: Item 5.07, Submission of matters to a vote of security holders. Source: https://www.sec.gov/Archives/edgar/data/1038277/000143774925022820/inis20250716_8k.htm
- Oct 2, 2024: Item 3.03, Material modification to rights of security holders; Item 5.03, Amendments to articles or bylaws; change in fiscal year; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1038277/000143774924030450/inis20240925_8k.htm

## Latest filings

- 8-K filed Oct 1, 2026: https://www.sec.gov/Archives/edgar/data/1038277/000143774926031655/inis20260930_8k.htm
- 10-K filed Mar 31, 2026: https://www.sec.gov/Archives/edgar/data/1038277/000143774926010700/inis20251231_10k.htm
- 10-Q filed Aug 12, 2026: https://www.sec.gov/Archives/edgar/data/1038277/000143774926027385/inis20260630_10q.htm
- DEF 14A filed Jun 4, 2026: https://www.sec.gov/Archives/edgar/data/1038277/000143774926019504/inis20260519_def14a.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/